AP Pharma Inc.
Description A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to release drugs over a defined period of time; and is applicable to a range of therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases. The companys lead product candidate is APF530, which has completed a Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting. Its development pipeline also includes two other product candidates, including APF112 for post-surgical pain relief; and APF580 that is designed to provide analgesia lasting at least seven days following a single injection. The company was formerly known as Advanced Polymer Systems, Inc. and changed its name to A.P. Pharma, Inc. in May 2001 to reflect its focus on pharmaceutical business. A.P. Pharma, Inc. was founded in 1983 and is headquartered in Redwood City, California. To view the detailed information, you need to SUBSCRIBE with us. |
 |